RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA

Clinical trials for RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Cholesterol drug may boost cancer treatment in new trial

Disease control Recruiting now

This study is testing whether adding the common cholesterol-lowering drug lovastatin to the immunotherapy drug pembrolizumab can better control head and neck cancer that has returned or spread. Researchers believe lovastatin may make cancer cells more vulnerable to the immune sys…

Matched conditions: RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA

Get alerted when new RECURRENT PARANASAL SINUS SQUAMOUS CELL CARCINOMA trials appear

Cholesterol drug may boost cancer treatment in new trial